OSE Immunotherapeutics Logo

OSE Immunotherapeutics | OSE - Profile, Filings, Stock Info & Investor Relations Data

OSE Immunotherapeutics | OSE
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Country
France
Founded
2016
OSE Immunotherapeutics (OSE)

About OSE Immunotherapeutics

OSE Immunotherapeutics is an integrated biotechnology company focused on developing and partnering therapies to control the immune system for immuno-oncology and autoimmune diseases.

Based in Nantes (Head Office) and Paris, OSE Immunotherapeutics has 70 employees and is listed on Euronext Paris.

Employees

70

Market Presence

Worldwide

Headquarters

22 BOULEVARD BENONI GOULLIN
44200, NANTES
France

OSE Immunotherapeutics (OSE)
Key Financial Data

AI-Powered Financial Insights Coming Soon

We are currently processing the filings for this company to provide automated financial statement analysis, key ratios, and risk summaries. Please check back later!

Unlock Full Company Insights & AI Chat

Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).

OSE Immunotherapeutics (OSE)
Filings & Annual Reports
Chat with AI, summarize, and extract data from processed filings! Look for the 'View & AI' button.

Quick Filters:

Advanced Filters

View all types
Filing Information Actions

Insider Trading Activity

N/A (Other)
Other EUR 35,700.00 EUR 3.57 19.06.24
N/A (Other)
Other EUR 35,800.00 EUR 3.58 17.06.24
N/A (Other)
Other EUR 35,700.00 EUR 3.57 17.06.24
N/A (Other)
Sell EUR 45,879.09 EUR 7.20 13.06.24
N/A (Other)
Sell EUR 314,512.00 EUR 7.86 03.06.24

OSE Immunotherapeutics (OSE)
Stock & Investor Information

ISINs

FR0012127173
FR0012581916
FR0012581932

LEI

969500HIUWVGY6NZSM05

Stock Exchange Listings

Euronext Paris

Primary Stock Exchange Listing

View OSE Immunotherapeutics on main exchange

Industry Classification